About us


Our aim is to help safeguard the quality of life in patients and their families, and to diminish the exponential costs that build up during therapy, burdening both the patients and society.

To this end, nine European countries will share human and material resources for four years (2019-2023) to train a generation of young researchers about the key culprits in cancer development: hormonal stimulation, chronic inflammation and lifestyle risks. Thousands of hours spent in labs across Europe showed our team that prevention starts with better understanding these factors

PA at the microscope

Patrick Aouad – Doctoral Assistant (Brisken Lab)


Cancer can’t be studied by working in silos. However, interactions between cancer biologists, epidemiologists, mathematicians and geneticists remain scarce. At CANCERPREV, we believe that the whole can be greater than the sum of its parts.

Cancer biologists and epidemiologists generally have few opportunities to study and work together in early career stages. However, epidemiological studies provide valuable insights into cancer trends. By getting cross-disciplinary training from top experts in their fields, the young researchers that will be recruited for this project will save years of study and clinical practice. At the end of the project they will hold PhD degrees and will be well equipped to help their communities in the face of increasing cancer rates.

It can take decades to transform research results into effective public health measures that could benefit all of us. Getting policy makers, public health scientists and health care providers on board would help fasttrack this process, leading to a decrease in cancer rates and the associated costs for society. This is why we commit to openly share the data and the results of our work, both with other scientists and with the public.